Wednesday, May 22, 2013

• Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma TrialCNW Group( (Wed, May 22)
• Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma TrialPR Newswire( (Wed, May 22)

Tuesday, May 14, 2013

• Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferenceCNW Group( (Tue, May 14)
• Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferencePR Newswire( (Tue, May 14)

Friday, May 10, 2013

• Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersCNW Group( (Fri, May 10)
• Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersPR Newswire( (Fri, May 10)

Thursday, May 9, 2013

• Oncolytics Biotech® Inc. Announces First Quarter 2013 ResultsCNW Group( (Thu, May 9)
• Oncolytics Biotech® Inc. Announces First Quarter 2013 ResultsPR Newswire( (Thu, May 9)

Monday, May 6, 2013

• Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of ShareholdersCNW Group( (Mon, May 6)
• Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of ShareholdersPR Newswire( (Mon, May 6)

Monday, April 29, 2013

• Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare ConferenceCNW Group( (Mon, Apr 29)
• Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare ConferencePR Newswire( (Mon, Apr 29)